Wavefront Analisys and Contrast Sensitivity of Spherical and Aspherical Intraocular Lenses

Sponsor
Federal University of São Paulo (Other)
Overall Status
Completed
CT.gov ID
NCT00347243
Collaborator
(none)
1
9

Study Details

Study Description

Brief Summary

Purpose:To compare visual performance, total and high order wavefront aberrations (coma, spherical aberration and other terms) and contrast sensitivity in eyes implanted with one monofocal aspheric intraocular lens (IOL) and two spherical IOLs (SofPort AO, Soflex,AcrySof®IQ (40 eyes), AcrySof®Natural and AMO®Sensar)

Condition or Disease Intervention/Treatment Phase
  • Procedure: phacoemulsification (cataract surgery)
Phase 4

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
Wavefront Analisys and Contrast Sensitivity of Spherical and Aspherical
Study Start Date :
Sep 1, 2005
Study Completion Date :
Jun 1, 2006

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    50 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Patients with bilateral visually significant senile cataract, corneal astigmatism less than 2.0 diopters and potential acuity meter (PAM) better than 0.2 LogMar
    Exclusion Criteria:
    • any other ocular diseases, such as corneal opacities or irregularity, dry eye, amblyopia, anisometropia, glaucoma, retinal abnormalities, surgical complications, IOL tilt, decentration (estimated by retro illumination and digital photo) greater than 0.4mm13 or loss of follow-up

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Federal University of Sao paulo Sao Paulo SP Brazil 04044-020

    Sponsors and Collaborators

    • Federal University of São Paulo

    Investigators

    • Study Director: Paulo Schor, MD, UNIFESP - EPM

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00347243
    Other Study ID Numbers:
    • CEP012/06
    First Posted:
    Jul 4, 2006
    Last Update Posted:
    Oct 26, 2006
    Last Verified:
    Mar 1, 2006
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 26, 2006